The authors declare that they have no competing interests.
All authors have reviewed and contributed to the content. AOT drafted the commentary for the group. All authors read and approved the final manuscript.
The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.
Arrow K, Panosian C, Gelband H: Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. 2004, Washington, DC: The National Academies Press
Final Report of the Independent Evaluation of AMFm Phase 1. http://www.theglobalfund.org/en/amfm/independentevaluation/,
Tougher S, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, Mann AG, Ren R, Willey BA, Adegoke CA, Amin A, Ansong D, Bruxvoort K, Diallo DA, Diap G, Festo C, Johanes B, Juma E, Kalolella A, Malam O, Mberu B, Ndiaye S, Nguah SB, Seydou M, Taylor M, Rueda ST, Wamukoya M, Arnold F, Hanson K, the ACTwatch Group: Eff ect of the Aff ordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012, http://dx.doi.org/10.1016/S0140-6736(12)61732-2,
Trape F: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001, 64 (1–2 Suppl): 12-7. PubMed
World Health Organization: World Malaria Report. 2011, Geneva, Switzerland: WHO
Institute for Health Metrics and Evaluation: Financing Global Health 2011: Continued Growth as MDG Deadline Approaches. 2011, Seattle, WA: IHME
- The affordable medicines facility-malaria—A success in peril
Ambrose O Talisuna
Chioma N Amojah
George K Amofah
Djermakoye H Jackou
Albert P Okui
Shija J Shija
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II